Leading Pharmaceutical Marketing Research and Consulting Company Introduces 'Intelligent Efficiency' Program

BLUE BELL, Pa., Feb. 1, 2012 /PRNewswire/ -- Evolution Marketing Research, the next generation pharmaceutical marketing research and consulting company, announced that it has proactively restructured in order to better take advantage of the evolving global pharmaceutical marketplace in coming years. As a keystone of this restructuring, the company has instituted a new strategy called "Intelligent Efficiency." This strategy is intended to allow the company to compete effectively in this new market environment with a streamlined organizational structure.

"Over the past decade, the pharmaceutical marketing research industry has known nothing but solid, often dramatic, growth. The pharmaceutical industry, however, has changed and the new definition of success in these trying economic times is stability rather than growth, in large part due to shrinking pharma marketing research budgets," said company Principal James Cummings. 

Evolution's founding principals look forward to a more stable market environment in the year to come which will allow for the development of new relationships in the biopharma industry. "By every definition of the term, Evolution had a stable year and is poised for success in the future," explains Daniel Slawe, Chief Operating Officer. "The restructuring of the company under our new Intelligent Efficiency program will allow us to continue to provide best-in-class service to our clients."

An important part of this drive will be the development of new and innovative research methodologies and products. "Evolution is constantly in the process of creating new key products, several of which will be launching over the course of this year [2012]," said Principal Dr. James Heasley. "This is in keeping with our corporate mission of continuing to innovate and lead in an industry that is always seeking to enhance efficiencies." In 2011, the company introduced a range of innovative methodologies such as the well-received PreSIM(SM) qualitative conjoint method and its ActiveInsight™ custom omnibus study. 

Through the Intelligent Efficiency initiative, Evolution is committed to introduction of new and original methodologies geared toward aiding clients to make the most of their resources.

About Evolution Marketing Research, LLC:

Evolution Marketing Research is a medical marketing research firm that provides qualitative and quantitative research, consulting services, project management, advisory board monitoring and other marketing research services to pharmaceutical, biotech and medical device companies all over the world. Company Principals John Taenzler, Ph.D., Jim Cummings, and James Heasley, Ph.D., who are backed by a seasoned team of analysts and researchers, bring their collective experience to bear on pharmaceutical projects at all phases of the product lifecycle, including opportunity and licensing assessments, product crafting in support of phase III clinical trial design, and development of the commercial platform for developmental and in-line products. To learn more, call (866) 486-0873 or visit http://www.evolved-mr.com.  

MEDIA CONTACT:

Inna Lobanova-Heasley
[email protected]
215-280-4824

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE Evolution Marketing Research, LLC